Neil O'Neill Gilmore, CEO at Editas Medicine, Inc. (EDIT), sold 5,124 shares at $3.04 ($16K) on 2026-09-03, disclosed to the SEC on 2026-09-04.
Open-market sale of $16k EDIT by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EDIT | SELL | 2025-12-04 | $12K | — | Filing → |
| EDIT | SELL | 2025-09-04 | $15K | — | Filing → |
| EDIT | SELL | 2025-06-04 | $26K | — | Filing → |